NORTH AMERICA BLOOD PLASMA MARKET FORECAST 2020-2028

  • You are here:
  • Home
  • Reports
  • NORTH AMERICA BLOOD PLASMA MARKET FORECAST 2020-2028

NORTH AMERICA BLOOD PLASMA MARKET FORECAST 2020-2028

The North America blood plasma market is estimated to record a CAGR of 6.13% during the forecast period, 2020-2028. The region has generated several advanced modalities belonging to blood plasma, and have developed various such therapies on a large scale. Also, the growing demand for plasmapheresis further propels the market growth of the region. The countries assessed for market analysis in the North America blood plasma market include the United States and Canada.

NORTH AMERICA BLOOD PLASMA MARKET FORECAST 2020-2028

North America Blood Plasma Market by Mode of Delivery (Infusion Solutions, Gels, Sprays, Biomedical Sealants) by Blood Type (Immunoglobulin, Albumin, Hyperimmunes, Coagulation Factor Concentrates, Other Plasma Fractionation Products) by Therapeutic Indication (Immunology, Oncology, Pulmonology, Rheumatology, Transplantation, Neurology, Hematology, Other Application) by Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand Disease (Vwd), Other Application)  by End User (Hospitals and Clinics, Research Laboratories, Academic Institutions) and by Geography.

Request free sample

The North America blood plasma market is estimated to record a CAGR of 6.13% during the forecast period, 2020-2028. The region has generated several advanced modalities belonging to blood plasma, and have developed various such therapies on a large scale. Also, the growing demand for plasmapheresis further propels the market growth of the region.
North America Blood Plasma Market

To know more about this report, request a free sample copy.

The countries assessed for market analysis in the North America blood plasma market include the United States and Canada. In the US, there is an increasing number of people that suffer from chronic diseases like hemophilia, which has led to the large scale employment of blood plasma in the region. The country is also a witness to increasing cases of leukemia, and various other severe disorders, which require blood plasma administration. According to the American Society of Plastic Surgeons, a considerable number of cosmetic surgeries were conducted in the United States. Influenza is deemed to be responsible for many deaths and hospitalizations each year in the country, which is driving the hyperimmune globulin market. According to an article in 2020, the New York State announced that it will be using the blood plasma of recovered patients for fighting the coronavirus outbreak.

Arthrex, Inc. (Arthrex) is a medical device company that manufactures and designs surgical products and solutions, which are used for arthroscopic and minimally invasive orthopedic surgical procedures.  The company markets its products through a network of distributors in Europe, the Middle East, Africa, Asia, and the Americas. The company has its headquarters in Naples, Florida, the US.

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • MARKET DEFINITION
    •    KEY DRIVERS
      • WIDESPREAD ACCEPTANCE OF IMMUNOGLOBULIN-BASED THERAPIES
      • GROWING USAGE OF ALBUMIN IN OTHER THERAPEUTIC AREAS
      • GROWING GERIATRIC POPULATION
      • RISING PREVALENCE OF ALPHA-1 ANTITRYPSIN DEFICIENCY (AATD)
      • INCREASE IN THE PATIENT POOL FOR HEMOPHILIA TREATMENT
    •    KEY RESTRAINTS
      • INCREASING USAGE OF RECOMBINANT PLASMA PRODUCTS IN THERAPEUTIC TREATMENTS
      • HIGH COSTS OF BLOOD PLASMA TREATMENTS
      • ADVERSE REACTIONS ASSOCIATED WITH POST-TRANSFUSION
      • SPREAD OF PATHOGENIC CONTAMINANTS
      • HIGH REGULATIONS IN THE MARKET
  1. KEY ANALYTICS
    •    PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRY
      • THREAT OF SUBSTITUTION
      • BUYER’S POWER
      • SUPPLIER’S POWER
      • COMPETITIVE RIVALRY
    • PLASMA THERAPEUTICS REGULATION
    • CLINICAL GUIDELINES
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • KEY INVESTMENT INSIGHTS
  2. MARKET BY MODE OF DELIVERY
    • INFUSION SOLUTIONS
    • GELS
    • SPRAYS
    • BIOMEDICAL SEALANTS
  3. MARKET BY DISORDER
    • IMMUNODEFICIENCY DISEASE
    • HYPOGAMMAGLOBULINEMIA
    • HEMOPHILIA
    • VON WILLEBRAND DISEASE (VWD)
    • OTHER DISORDERS
  4. MARKET BY BLOOD PLASMA DERIVATIVES
    •    IMMUNOGLOBULIN
      • INTRAVENOUS IMMUNOGLOBULIN
      • SUBCUTANEOUS IMMUNOGLOBULIN
      • OTHER IMMUNOGLOBULIN TYPES
    • ALBUMIN
    • HYPERIMMUNE
    • COAGULATION FACTOR CONCENTRATES
    • OTHER PLASMA FRACTIONATION PRODUCTS
  5. MARKET BY THERAPEUTIC INDICATION
    • NEUROLOGY
    • IMMUNOLOGY
    • ONCOLOGY
    • TRANSPLANTATION
    • HEMATOLOGY
    • RHEUMATOLOGY
    • PULMONOLOGY
    • OTHER THERAPEUTIC INDICATION
  6. MARKET BY END-USER
    • HOSPITALS AND CLINICS
    • RESEARCH LABORATORIES
    • ACADEMIC INSTITUTIONS
  7. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. COMPANY PROFILES
    • ADMA BIOLOGICS
    • ARTHREX
    • BIO PRODUCTS LABORATORY
    • BAXTER INTERNATIONAL
    • BIOTEST AG
    • CERUS CORPORATION (CERUS)
    • CHINA BIOLOGIC PRODUCTS
    • CSL LIMITED
    • FUSION HEALTH CARE
    • GREEN CROSS HOLDINGS CORPORATION
    • GRIFOLS
    • LFB
    • OCTAPHARMA
    • TAKEDA PHARMACEUTICAL COMPANY
    • KEDRION BIOPHARMA INC

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT – BLOOD PLASMA

TABLE 2: NORTH AMERICA BLOOD PLASMA MARKET, BY DISORDER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 3: NORTH AMERICA BLOOD PLASMA MARKET, BY DISORDER, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 4: NORTH AMERICA BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 5: NORTH AMERICA BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 6: NORTH AMERICA BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 7: NORTH AMERICA BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 8: NORTH AMERICA BLOOD PLASMA MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 9: NORTH AMERICA BLOOD PLASMA MARKET, BY END-USER, FORECAST YEARS, 2020-2028 (IN $ MILLION)

TABLE 10: NORTH AMERICA BLOOD PLASMA, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)

TABLE 11: NORTH AMERICA BLOOD PLASMA, BY COUNTRY, FORECAST YEARS, 2020-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: PORTER’S FIVE FORCE ANALYSIS

FIGURE 2: OPPORTUNITY MATRIX

FIGURE 3: VENDOR LANDSCAPE

FIGURE 4: KEY INVESTMENT INSIGHTS

FIGURE 5: IMMUNOGLOBULIN INFUSIONS SIDE EFFECTS

FIGURE 6: ROLE OF FIBRIN SEALANT IN COAGULATION CASCADE

FIGURE 7: NORTH AMERICA BLOOD PLASMA MARKET, BY DISORDER, IN 2019

FIGURE 8: NORTH AMERICA BLOOD PLASMA MARKET, BY IMMUNODEFICIENCY DISEASE, 2020-2028 (IN $ MILLION)

FIGURE 9: NORTH AMERICA BLOOD PLASMA MARKET, BY HYPOGAMMAGLOBULINEMIA, 2020-2028 (IN $ MILLION)

FIGURE 10: NORTH AMERICA BLOOD PLASMA MARKET, BY HEMOPHILIA, 2020-2028 (IN $ MILLION)

FIGURE 11: NORTH AMERICA BLOOD PLASMA MARKET, BY VON WILLEBRAND DISEASE (VWD), 2020-2028 (IN $ MILLION)

FIGURE 12: NORTH AMERICA BLOOD PLASMA MARKET, BY OTHER DISORDERS, 2020-2028 (IN $ MILLION)

FIGURE 13: NORTH AMERICA BLOOD PLASMA MARKET, BY BLOOD DERIVATIVES, IN 2019

FIGURE 14: NORTH AMERICA BLOOD PLASMA MARKET, BY IMMUNOGLOBULIN, 2020-2028 (IN $ MILLION)

FIGURE 15: NORTH AMERICA IMMUNOGLOBULIN MARKET, BY INTRAVENOUS IMMUNOGLOBULIN, 2020-2028 (IN $ MILLION)

FIGURE 16: NORTH AMERICA IMMUNOGLOBULIN MARKET, BY SUBCUTANEOUS IMMUNOGLOBULIN, 2020-2028 (IN $ MILLION)

FIGURE 17: NORTH AMERICA IMMUNOGLOBULIN MARKET, BY OTHER IMMUNOGLOBULIN TYPES, 2020-2028 (IN $ MILLION)

FIGURE 18: NORTH AMERICA BLOOD PLASMA MARKET, BY ALBUMIN, 2020-2028 (IN $ MILLION)

FIGURE 19: NORTH AMERICA BLOOD PLASMA MARKET, BY HYPERIMMUNE, 2020-2028 (IN $ MILLION)

FIGURE 20: HYPERIMMUNES ISOLATION PROCESS

FIGURE 21: NORTH AMERICA BLOOD PLASMA MARKET, BY COAGULATION FACTOR CONCENTRATES, 2020-2028 (IN $ MILLION)

FIGURE 22: NORTH AMERICA BLOOD PLASMA MARKET, BY OTHER PLASMA FRACTIONATION PRODUCTS, 2020-2028 (IN $ MILLION)

FIGURE 23: NORTH AMERICA BLOOD PLASMA MARKET, BY THERAPEUTIC INDICATION, IN 2019

FIGURE 24: NORTH AMERICA BLOOD PLASMA MARKET, BY NEUROLOGY, 2020-2028 (IN $ MILLION)

FIGURE 25: NORTH AMERICA BLOOD PLASMA MARKET, BY IMMUNOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 26: NORTH AMERICA BLOOD PLASMA MARKET, BY ONCOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 27: NORTH AMERICA BLOOD PLASMA MARKET, BY TRANSPLANTATION, 2020-2028 (IN $ MILLION)

FIGURE 28: NORTH AMERICA BLOOD PLASMA MARKET, BY HEMATOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 29: NORTH AMERICA BLOOD PLASMA MARKET, BY RHEUMATOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 30: LUPUS INFECTION SYMPTOMS

FIGURE 31: NORTH AMERICA BLOOD PLASMA MARKET, BY PULMONOLOGY, 2020-2028 (IN $ MILLION)

FIGURE 32: NORTH AMERICA BLOOD PLASMA MARKET, BY OTHER THERAPEUTIC INDICATION, 2020-2028 (IN $ MILLION)

FIGURE 33: NORTH AMERICA BLOOD PLASMA MARKET, BY END-USER, IN 2019

FIGURE 34: NORTH AMERICA BLOOD PLASMA MARKET, BY HOSPITALS AND CLINICS, 2020-2028 (IN $ MILLION)

FIGURE 35: NORTH AMERICA BLOOD PLASMA MARKET, BY RESEARCH LABORATORIES, 2020-2028 (IN $ MILLION)

FIGURE 36: NORTH AMERICA BLOOD PLASMA MARKET, BY ACADEMIC INSTITUTIONS, 2020-2028 (IN $ MILLION)

FIGURE 37: NORTH AMERICA BLOOD PLASMA MARKET, COUNTRY OUTLOOK, 2019 & 2028 (IN %)

FIGURE 38: THE UNITED STATES BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

FIGURE 39: CANADA BLOOD PLASMA MARKET, 2020-2028 (IN $ MILLION)

  1. GEOGRAPHICAL ANALYSIS
    •    NORTH AMERICA
      • THE UNITED STATES
      • CANADA
  1. MARKET BY MODE OF DELIVERY
    • INFUSION SOLUTIONS
    • GELS
    • SPRAYS
    • BIOMEDICAL SEALANTS
  2. MARKET BY DISORDER
    • IMMUNODEFICIENCY DISEASE
    • HYPOGAMMAGLOBULINEMIA
    • HEMOPHILIA
    • VON WILLEBRAND DISEASE (VWD)
    • OTHER DISORDERS
  3. MARKET BY BLOOD PLASMA DERIVATIVES
    •    IMMUNOGLOBULIN
      • INTRAVENOUS IMMUNOGLOBULIN
      • SUBCUTANEOUS IMMUNOGLOBULIN
      • OTHER IMMUNOGLOBULIN TYPES
    • ALBUMIN
    • HYPERIMMUNE
    • COAGULATION FACTOR CONCENTRATES
    • OTHER PLASMA FRACTIONATION PRODUCTS
  4. MARKET BY THERAPEUTIC INDICATION
    • NEUROLOGY
    • IMMUNOLOGY
    • ONCOLOGY
    • TRANSPLANTATION
    • HEMATOLOGY
    • RHEUMATOLOGY
    • PULMONOLOGY
    • OTHER THERAPEUTIC INDICATION
  5. MARKET BY END-USER
    • HOSPITALS AND CLINICS
    • RESEARCH LABORATORIES
    • ACADEMIC INSTITUTIONS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now